This study adds to the body of evidence that, if biopsy, cytological, and surgical specimens are handled appropriately, they can all be used to yield a valid PD‐L1 TPS for PD‐L1 expression in NSCLC to guide clinical management. The gene discussed is CD274; the disease is non-small cell lung carcinoma.